metforminPapers
Papers about metformin
- papers
- 3,984
Newest first
2,001 to 2,050 of 3,984Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin
Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial.
Diabetes, obesity & metabolism2018PMID 28926170
Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial.
Diabetes, obesity & metabolism2018PMID 28940961
Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.
Microvascular research2018PMID 28954218
Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.
Diabetes, obesity & metabolism2018PMID 28967181
Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Journal of psychosomatic obstetrics and gynaecology2018PMID 28980870Indexed under metformin in PubMed's chemical list
Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis.
Diabetic medicine2018PMID 29044702
Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily injections of exenatide in type 2 diabetics using metformin.
Diabetes, obesity & metabolism2018PMID 29053202
Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial.
Gynecological endocrinology2018PMID 29076376
Metformin effect on TSH in subclinical hypothyroidism: randomized, double-blind, placebo-controlled clinical trial.
Endocrine2018PMID 29080044
Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: A randomized study.
The journal of obstetrics and gynaecology research2018PMID 29094444
Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Current pharmaceutical design2018PMID 29110599
Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver Fat and Slower Bone Maturation.
Hormone research in paediatrics2018PMID 29131093
Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury.
American journal of physiology2018PMID 29138224
Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.
Diabetes, obesity & metabolism2018PMID 29144061
DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
Endocrine practice2018PMID 29144805Returned by a PubMed search for metformin
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS.
The Journal of clinical endocrinology and metabolism2018PMID 29165598
Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
Diabetes & metabolic syndrome2018PMID 29221717
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial.
Diabetes, obesity & metabolism2018PMID 29227571
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.
Diabetes care2018PMID 29246950Indexed under metformin in PubMed's chemical list
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Diabetes, obesity & metabolism2018PMID 29266675
Is metformin poised for a second career as an antimicrobial?
Diabetes/metabolism research and reviews2018PMID 29271563
All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes.
Endocrine research2018PMID 29308936
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.
Diabetes, obesity & metabolism2018PMID 29316164
Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.
BMC cancer2018PMID 29320995
Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
Clinical infectious diseases2018PMID 29325084
The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome.
The Journal of clinical endocrinology and metabolism2018PMID 29325133
How safe is metformin when initiated in early pregnancy? A retrospective 5-year study of pregnant women with gestational diabetes mellitus from India.
Diabetes research and clinical practice2018PMID 29325773
TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH).
Diabetes care2018PMID 29326107
Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
PloS one2018PMID 29329345
The effects of metformin in type 1 diabetes mellitus.
BMC endocrine disorders2018PMID 29338714
A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.
PloS one2018PMID 29342199
Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials.
Diabetes/metabolism research and reviews2018PMID 29351716
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
Cardiovascular diabetology2018PMID 29368615
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors as add-on to metformin and sulfonylurea treatment for the management of type 2 diabetes: a meta-analysis.
Endocrine journal2018PMID 29375082
Two-year trial of intermittent insulin therapy vs metformin for the preservation of β-cell function after initial short-term intensive insulin induction in early type 2 diabetes.
Diabetes, obesity & metabolism2018PMID 29377408
Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity.
Clinical science (London, England2018PMID 29382697
Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan.
PloS one2018PMID 29385156
In Vivo Evaluation of the Synergic Effect of Metformin and mTOR Inhibitors on the Endothelial Healing of Drug-eluting Stents in Diabetic Patients.
Revista espanola de cardiologia (English ed.)2018PMID 29396233
Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: A 3-month placebo-controlled clinical trial in patients with type 2 diabetes and healthy controls.
Diabetes, obesity & metabolism2018PMID 29405635
The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
BJOG2018PMID 29412502
Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
International journal of cancer2018PMID 29435974
A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.
Diabetes, obesity & metabolism2018PMID 29436761
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin.
Diabetes, obesity & metabolism2018PMID 29446523
The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter.
Acta clinica Belgica2018PMID 29452573
Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.
Cancer epidemiology2018PMID 29453032
Pharmacokinetics of metformin in patients with gastrointestinal intolerance.
Diabetes, obesity & metabolism2018PMID 29457876
Metformin Use and Severe Dengue in Diabetic Adults.
Scientific reports2018PMID 29463812
Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Medicine2018PMID 29465545
Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis.
Diabetes & metabolism2018PMID 29477373Returned by a PubMed search for metformin
Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
BMC endocrine disorders2018PMID 29482528